Session

PP 02 H. pylori (Posters)

ANTIBIOTIC SUSCEPTIBILITY PATTERNS AND CLARITHROMYCIN RESISTANCE DETERMINANTS IN HELICOBACTER PYLORI IN NORTHEAST OF SPAIN. A ONE-YEAR PROSPECTIVE STUDY
ANTIBIOTIC SUSCEPTIBILITY PATTERNS AND CLARITHROMYCIN RESISTANCE DETERMINANTS IN HELICOBACTER PYLORI IN NORTHEAST OF SPAIN. A ONE-YEAR PROSPECTIVE STUDY

PP 02 H. pylori (Posters)  et al.

EFFICACY AND TOLERABILITY OF BISMUTH-BASED ERADICATION THERAPY WITHOUT PROTON PUMP INHIBITORS FOR HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CORPUS ATROPHIC GASTRITIS: A RETROSPECTIVE SINGLE-CENTER EXPERIENCE
EFFICACY AND TOLERABILITY OF BISMUTH-BASED ERADICATION THERAPY WITHOUT PROTON PUMP INHIBITORS FOR HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CORPUS ATROPHIC GASTRITIS: A RETROSPECTIVE SINGLE-CENTER EXPERIENCE

PP 02 H. pylori (Posters)  et al.

EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING
EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING

PP 02 H. pylori (Posters)  et al.

RELATIONSHIP BETWEEN HELICOBACTER PYLORI INFECTION AND GASTRIC MUCOSAL INJURIES IN PATIENTS TAKING ASPIRIN
RELATIONSHIP BETWEEN HELICOBACTER PYLORI INFECTION AND GASTRIC MUCOSAL INJURIES IN PATIENTS TAKING ASPIRIN

PP 02 H. pylori (Posters)  et al.

PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI
PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI

PP 02 H. pylori (Posters)  et al.

DYSPEPSIA AND PSYCHOLOGICAL STATE IN PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED CHRONIC GASTRITIS AND VIRULENCE FACTORS CAGA+, VACA+
DYSPEPSIA AND PSYCHOLOGICAL STATE IN PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED CHRONIC GASTRITIS AND VIRULENCE FACTORS CAGA+, VACA+

INCIDENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER PATIENTS IN ALBANIA: ASSOCIATION WITH HISTOPATHOLOGICAL FORMS AND CLINICAL CHARACTERISTICS - A SINGLE-CENTER STUDY
INCIDENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER PATIENTS IN ALBANIA: ASSOCIATION WITH HISTOPATHOLOGICAL FORMS AND CLINICAL CHARACTERISTICS - A SINGLE-CENTER STUDY

EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING
EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING

PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI
PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI

GHRELIN AND LEPTIN FOR NON-INVASIVE DIAGNOSIS OF ADVANCED ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA
GHRELIN AND LEPTIN FOR NON-INVASIVE DIAGNOSIS OF ADVANCED ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA

ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND NASAL POLYPS: Α SYSTEMATIC REVIEW AND META-ANALYSIS
ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND NASAL POLYPS: Α SYSTEMATIC REVIEW AND META-ANALYSIS

IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE
IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE

HELICOBACTER PYLORI AND SARS- COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
HELICOBACTER PYLORI AND SARS- COV-2: A DANGEROUS PATHOGENETIC CORRELATION?

HELICOBACTER PYLORI WITH TRX1 HIGH EXPRESSION PROMOTES GASTRIC DISEASES BY UPREGULATING THE IL23A/NF-ΚB /IL8 PATHWAY
HELICOBACTER PYLORI WITH TRX1 HIGH EXPRESSION PROMOTES GASTRIC DISEASES BY UPREGULATING THE IL23A/NF-ΚB /IL8 PATHWAY

INFLUENCE OF CYTOKINE GENETIC POLYMORPHISMS IN HELICOBACTER PYLORI–ASSOCIATED GASTRIC INFLAMMATION ACCORDING TO SEX IN SOUTH KOREA
INFLUENCE OF CYTOKINE GENETIC POLYMORPHISMS IN HELICOBACTER PYLORI–ASSOCIATED GASTRIC INFLAMMATION ACCORDING TO SEX IN SOUTH KOREA

ANTIBIOTIC SUSCEPTIBILITY PATTERNS AND CLARITHROMYCIN RESISTANCE DETERMINANTS IN HELICOBACTER PYLORI IN NORTHEAST OF SPAIN. A ONE-YEAR PROSPECTIVE STUDY
ANTIBIOTIC SUSCEPTIBILITY PATTERNS AND CLARITHROMYCIN RESISTANCE DETERMINANTS IN HELICOBACTER PYLORI IN NORTHEAST OF SPAIN. A ONE-YEAR PROSPECTIVE STUDY

EFFICACY AND TOLERABILITY OF BISMUTH-BASED ERADICATION THERAPY WITHOUT PROTON PUMP INHIBITORS FOR HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CORPUS ATROPHIC GASTRITIS: A RETROSPECTIVE SINGLE-CENTER EXPERIENCE
EFFICACY AND TOLERABILITY OF BISMUTH-BASED ERADICATION THERAPY WITHOUT PROTON PUMP INHIBITORS FOR HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CORPUS ATROPHIC GASTRITIS: A RETROSPECTIVE SINGLE-CENTER EXPERIENCE

RELATIONSHIP BETWEEN HELICOBACTER PYLORI INFECTION AND GASTRIC MUCOSAL INJURIES IN PATIENTS TAKING ASPIRIN
RELATIONSHIP BETWEEN HELICOBACTER PYLORI INFECTION AND GASTRIC MUCOSAL INJURIES IN PATIENTS TAKING ASPIRIN

THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS
THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS

PREVENTIVE EFFECT OF HELICOBACTER PYLORI ERADICATION ON THE ISCHEMIC STROKE AND CEREBRAL ATHEROSCLEROSIS
PREVENTIVE EFFECT OF HELICOBACTER PYLORI ERADICATION ON THE ISCHEMIC STROKE AND CEREBRAL ATHEROSCLEROSIS

Item 21 - 40 / 50
1
2
3